RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
RSSYX
Price
$24.10
Change
-$0.07 (-0.29%)
Updated
Sep 20 closing price
Ad is loading...

RPTIX vs RSSYX

Header iconRPTIX vs RSSYX Comparison
Open Charts RPTIX vs RSSYXBanner chart's image
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
Victory RS Select Growth Y
Price$24.10
Change-$0.07 (-0.29%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RPTIX vs RSSYX Comparison Chart
Loading...
VS
RPTIX vs. RSSYX commentary
Sep 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPTIX is a StrongBuy and RSSYX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. RSSYX (93.5M). RPTIX pays higher dividends than RSSYX: RPTIX (0.18) vs RSSYX (0.00). RPTIX was incepted earlier than RSSYX: RPTIX (9 years) vs RSSYX (15 years). RSSYX is a more actively managed with annual turnover of: 137.00 vs. RPTIX (21.70). RPTIX has a lower initial minimum investment than RSSYX: RPTIX (500000) vs RSSYX (1000000). RSSYX annual gain was more profitable for investors over the last year : 26.88 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. RSSYX (-36.84).
RPTIXRSSYXRPTIX / RSSYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years15 years-
Gain YTD9.12714.87661%
Front LoadN/AN/A-
Min. Initial Investment500000100000050%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B93.5M33,583%
Annual Yield % from dividends0.180.00-
Returns for 1 year14.8126.8855%
Returns for 3 years-13.57-45.3930%
Returns for 5 years15.09-36.84-41%
Returns for 10 yearsN/A-48.76-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp